$INKT
MiNK Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · New York, NY
INKT chart
What traders are saying about $INKT
Latest postsMiNK Therapeutics, Inc. news
- H.C. Wainwright Maintains MiNK Therapeutics(INKT.US) With Buy Rating, Maintains Target Price $38
Moomoo ·
- Mink Therapeutics Inc expected to post a loss of 50 cents a share - Earnings Preview
TradingView ·
- Weekly Recap: Buy rating with $38 target and Q3 2026 results date set
TradingView ·
- MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell...
Quantisnow ·
- MiNK Therapeutics shows new data on iNKT cell t...
Pluang ·
- MiNK Therapeutics presents preclinical iNKT cell therapy data at SITC
StreetInsider ·
- MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell Therapy Targets Two Key Mechanisms of Tumor Resistance Presented at the Society of Immunotherapy of Cancer (SITC 2026)
Yahoo Finance ·
- MiNK Therapeutics Price Target Announced at $38.00/Share by HC Wainwright & Co.
Moomoo ·
- HC Wainwright & Co. assumes coverage of MiNK Therapeutics at Buy, sets price target at $38
TradingView ·
- H.C. Wainwright Initiates MiNK Therapeutics(INKT.US) With Buy Rating, Announces Target Price $38
Moomoo ·
- MiNK Therapeutics stock initiated at buy by H.C. Wainwright
Investing.com ·
- MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy
Yahoo Finance ·
MiNK Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$12.5M | -$10.8M | -$22.5M | -$28.0M |
| Diluted EPS | $-2.93 | $-2.86 | $-6.54 | $-0.83 |
| Total assets (year end) | $14.2M | $5.7M | $4.6M | $21.5M |
| Cash and equivalents (year end) | $13.4M | $4.6M | $3.4M | $19.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About MiNK Therapeutics, Inc.
- Ticker
- INKT (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1840229
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
Frequently asked questions
What exchange is MiNK Therapeutics, Inc. listed on?
MiNK Therapeutics, Inc. trades on the Nasdaq under the ticker symbol INKT.
What industry is MiNK Therapeutics, Inc. in?
MiNK Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is MiNK Therapeutics, Inc. headquartered?
MiNK Therapeutics, Inc.'s business address on file with the SEC is in New York, NY.
When does MiNK Therapeutics, Inc.'s fiscal year end?
MiNK Therapeutics, Inc.'s fiscal year ends on December 31.